ArticleJournal of nanobiotechnology2025

Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants.

Chaofeng Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.